Cannabis Improves Clinical Outcomes and Quality of Life in Patients With Chronic Pouchitis

ACG Case Rep J. 2023 Aug 17;10(8):e01131. doi: 10.14309/crj.0000000000001131. eCollection 2023 Aug.

ABSTRACT

Many patients with ulcerative colitis after ileoanal pouch anastomosis report improvement of pouchitis with the use of cannabis. Nine patients with chronic pouchitis used 1 g/d of cannabis: 7 patients were male with average age 51 ± 16 years. Average partial pouchitis disease activity index were 11 (range 8-17), 6 (range 5-8), and 5 (range 4-8); endoscopic subscores were 7 .3 ± 2.3, 6 ± 1.1, and 4.4 ± 0.9; average bowel movements per day were 14 (range 8-20), 8 (range 2-13), and 10 (range 13-8); and quality of life increased from 72 ± 1 to 90 ± 16 and 97 ± 10 (P = 0.001) before cannabis treatment and after 8-12 and 52 weeks, respectively. No adverse events were reported.

PMID:37601299 | PMC:PMC10435015 | DOI:10.14309/crj.0000000000001131